Capricor Therapeutics CAPR Business Segments — Labor And Related Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's business segments — labor and related expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Capricor Therapeutics's business segments — labor and related expense?
- Capricor Therapeutics (CAPR) reported business segments — labor and related expense of $2.23M in Q1 2026.
- What does business segments — labor and related expense mean?
- This metric measures the direct cash compensation, benefits, and payroll-related costs for personnel assigned to the primary business segment. It serves as a proxy for the human capital investment required to maintain operational and administrative functions. Analyzing this helps assess the company's fixed cost structure and its ability to manage workforce-related overhead.